Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy

Summary: Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat patients are necessary. Invariant natural killer T (iNKT) cells are ideal cell carriers for developing allogenei...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yan-Ruide Li, Yang Zhou, Yu Jeong Kim, Yanni Zhu, Feiyang Ma, Jiaji Yu, Yu-Chen Wang, Xianhui Chen, Zhe Li, Samuel Zeng, Xi Wang, Derek Lee, Josh Ku, Tasha Tsao, Christian Hardoy, Jie Huang, Donghui Cheng, Amélie Montel-Hagen, Christopher S. Seet, Gay M. Crooks, Sarah M. Larson, Joshua P. Sasine, Xiaoyan Wang, Matteo Pellegrini, Antoni Ribas, Donald B. Kohn, Owen Witte, Pin Wang, Lili Yang
Format: article
Langue:EN
Publié: Elsevier 2021
Sujets:
hematopoietic stem cell
invariant natural killer T cells
cancer immunotherapy
allogeneic off-the-shelf cell therapy
chimeric antigen receptor
allogeneic HSC-engineered iNKT cells
Medicine (General)
R5-920
Accès en ligne:https://doaj.org/article/64abb953f8fd44bf8d0230b66356f289
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/64abb953f8fd44bf8d0230b66356f289

Documents similaires